{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:18:59Z","timestamp":1774775939282,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10928-018-9578-9","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T14:20:41Z","timestamp":1518618041000},"page":"401-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors"],"prefix":"10.1007","volume":"45","author":[{"given":"Tanaya","family":"Vaidya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Kamta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Chaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Ande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-3150","authenticated-orcid":false,"given":"Sihem","family":"Ait-Oudhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"issue":"2","key":"9578_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2010.08.026","volume":"249","author":"BB Hasinoff","year":"2010","unstructured":"Hasinoff BB, Patel D (2010) The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro. Toxicol Appl Pharmacol 249(2):132\u2013139","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"9578_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.taap.2009.12.032","volume":"244","author":"BB Hasinoff","year":"2010","unstructured":"Hasinoff BB (2010) The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity. Toxicol Appl Pharmacol 244(2):190\u2013195","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"9578_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1158\/1078-0432.CCR-07-4175","volume":"14","author":"M Brave","year":"2008","unstructured":"Brave M et al (2008) Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res 14(2):352\u2013359","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9578_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1634\/theoncologist.12-4-426","volume":"12","author":"D Strumberg","year":"2007","unstructured":"Strumberg D et al (2007) Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors. Oncologist 12(4):426\u2013437","journal-title":"Oncologist"},{"issue":"2","key":"9578_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa060655","volume":"356","author":"B Escudier","year":"2007","unstructured":"Escudier B et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125\u2013134","journal-title":"N Engl J Med"},{"issue":"5","key":"9578_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nrc2106","volume":"7","author":"T Force","year":"2007","unstructured":"Force T, Krause DS, Van Etten RA (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7(5):332\u2013344","journal-title":"Nat Rev Cancer"},{"key":"9578_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2091-3-32","volume":"3","author":"MT Chou","year":"2002","unstructured":"Chou MT, Wang J, Fujita DJ (2002) Src kinase becomes preferentially associated with the VEGFR, KDR\/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 3:32","journal-title":"BMC Biochem"},{"issue":"10","key":"9578_CR8","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1002\/stem.171","volume":"27","author":"W Altarche-Xifro","year":"2009","unstructured":"Altarche-Xifro W et al (2009) Cardiac c-kit\u00a0+\u00a0AT2\u00a0+\u00a0cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells 27(10):2488\u20132497","journal-title":"Stem Cells"},{"issue":"1","key":"9578_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/toxsci\/kfn157","volume":"106","author":"Y Will","year":"2008","unstructured":"Will Y et al (2008) Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells. Toxicol Sci 106(1):153\u2013161","journal-title":"Toxicol Sci"},{"issue":"5","key":"9578_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0192623310373775","volume":"38","author":"KJ French","year":"2010","unstructured":"French KJ et al (2010) Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicity. Toxicol Pathol 38(5):691\u2013702","journal-title":"Toxicol Pathol"},{"key":"9578_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fphar.2016.00151","volume":"7","author":"N Prieto-Dominguez","year":"2016","unstructured":"Prieto-Dominguez N et al (2016) Modulation of autophagy by sorafenib: effects on treatment response. Front Pharmacol 7:151","journal-title":"Front Pharmacol"},{"key":"9578_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.critrevonc.2016.02.006","volume":"100","author":"Y Heqing","year":"2016","unstructured":"Heqing Y et al (2016) The role and mechanism of autophagy in sorafenib targeted cancer therapy. Crit Rev Oncol Hematol 100:137\u2013140","journal-title":"Crit Rev Oncol Hematol"},{"issue":"21","key":"9578_CR13","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1002\/cncr.25426","volume":"116","author":"XF Le","year":"2010","unstructured":"Le XF et al (2010) Dasatinib induces autophagic cell death in human ovarian cancer. Cancer 116(21):4980\u20134990","journal-title":"Cancer"},{"issue":"2","key":"9578_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1158\/1535-7163.MCT-08-0669","volume":"8","author":"V Milano","year":"2009","unstructured":"Milano V et al (2009) Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Mol Cancer Ther 8(2):394\u2013406","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"9578_CR15","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.18632\/oncotarget.3357","volume":"6","author":"X Yang","year":"2015","unstructured":"Yang X et al (2015) Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling. Oncotarget 6(8):6203\u20136217","journal-title":"Oncotarget"},{"issue":"5497","key":"9578_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290(5497):1717\u20131721","journal-title":"Science"},{"issue":"7","key":"9578_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4161\/auto.6.7.12113","volume":"6","author":"M Dewaele","year":"2010","unstructured":"Dewaele M, Maes H, Agostinis P (2010) ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 6(7):838\u2013854","journal-title":"Autophagy"},{"issue":"5","key":"9578_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A et al (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13(5):619\u2013624","journal-title":"Nat Med"},{"issue":"1","key":"9578_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2008.163","volume":"16","author":"K Nishida","year":"2009","unstructured":"Nishida K et al (2009) The role of autophagy in the heart. Cell Death Differ 16(1):31\u201338","journal-title":"Cell Death Differ"},{"issue":"2","key":"9578_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0008-6363(01)00290-5","volume":"51","author":"MW Knaapen","year":"2001","unstructured":"Knaapen MW et al (2001) Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51(2):304\u2013312","journal-title":"Cardiovasc Res"},{"issue":"7","key":"9578_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.RES.0000067471.95890.5C","volume":"92","author":"S Kostin","year":"2003","unstructured":"Kostin S et al (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92(7):715\u2013724","journal-title":"Circ Res"},{"issue":"1","key":"9578_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yjmcc.2005.03.003","volume":"39","author":"MM Davidson","year":"2005","unstructured":"Davidson MM et al (2005) Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 39(1):133\u2013147","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"9578_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0163-7258(82)90051-1","volume":"16","author":"NH Holford","year":"1982","unstructured":"Holford NH, Sheiner LB (1982) Kinetics of pharmacologic response. Pharmacol Ther 16(2):143\u2013166","journal-title":"Pharmacol Ther"},{"issue":"3","key":"9578_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1152\/physrev.00024.2010","volume":"91","author":"MA Sussman","year":"2011","unstructured":"Sussman MA et al (2011) Myocardial AKT: the omnipresent nexus. Physiol Rev 91(3):1023\u20131070","journal-title":"Physiol Rev"},{"issue":"2","key":"9578_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta SR et al (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231\u2013241","journal-title":"Cell"},{"issue":"2","key":"9578_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0092-8674(95)90411-5","volume":"80","author":"E Yang","year":"1995","unstructured":"Yang E et al (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80(2):285\u2013291","journal-title":"Cell"},{"issue":"3","key":"9578_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","volume":"2","author":"A Letai","year":"2002","unstructured":"Letai A et al (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2(3):183\u2013192","journal-title":"Cancer Cell"},{"issue":"18","key":"9578_CR28","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.1074\/jbc.272.18.11671","volume":"272","author":"T Ito","year":"1997","unstructured":"Ito T et al (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272(18):11671\u201311673","journal-title":"J Biol Chem"},{"issue":"4","key":"9578_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.leu.2402090","volume":"15","author":"PP Ruvolo","year":"2001","unstructured":"Ruvolo PP, Deng X, May WS (2001) Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15(4):515\u2013522","journal-title":"Leukemia"},{"issue":"6109","key":"9578_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.1225967","volume":"338","author":"RC Wang","year":"2012","unstructured":"Wang RC et al (2012) Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338(6109):956\u2013959","journal-title":"Science"},{"issue":"3","key":"9578_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1097-2765(04)00028-0","volume":"13","author":"C Yu","year":"2004","unstructured":"Yu C et al (2004) JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13(3):329\u2013340","journal-title":"Mol Cell"},{"issue":"2","key":"9578_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd3252","volume":"10","author":"T Force","year":"2011","unstructured":"Force T, Kolaja KL (2011) Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov 10(2):111\u2013126","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"9578_CR33","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1073\/pnas.96.14.8144","volume":"96","author":"J Narula","year":"1999","unstructured":"Narula J et al (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96(14):8144\u20138149","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9578_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"J Zha","year":"1996","unstructured":"Zha J et al (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87(4):619\u2013628","journal-title":"Cell"},{"issue":"28","key":"9578_CR35","doi-asserted-by":"publisher","first-page":"20340","DOI":"10.1074\/jbc.M702210200","volume":"282","author":"TH Tran","year":"2007","unstructured":"Tran TH et al (2007) Jun kinase delays caspase-9 activation by interaction with the apoptosome. J Biol Chem 282(28):20340\u201320350","journal-title":"J Biol Chem"},{"key":"9578_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fonc.2014.00054","volume":"4","author":"KM Bernt","year":"2014","unstructured":"Bernt KM, Hunger SP (2014) Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia. Front Oncol 4:54","journal-title":"Front Oncol"},{"issue":"2","key":"9578_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"RJ Davis","year":"2000","unstructured":"Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103(2):239\u2013252","journal-title":"Cell"},{"issue":"3","key":"9578_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4161\/auto.22971","volume":"9","author":"D Dutta","year":"2013","unstructured":"Dutta D et al (2013) Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity. Autophagy 9(3):328\u2013344","journal-title":"Autophagy"},{"issue":"8","key":"9578_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1006\/jmcc.2000.1177","volume":"32","author":"K Kuwahara","year":"2000","unstructured":"Kuwahara K et al (2000) Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol 32(8):1385\u20131394","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"9578_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2004.11.005","volume":"38","author":"T Matsui","year":"2005","unstructured":"Matsui T, Rosenzweig A (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38(1):63\u201371","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"9578_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/toxsci\/kfq378","volume":"120","author":"HR Mellor","year":"2011","unstructured":"Mellor HR et al (2011) Cardiotoxicity associated with targeting kinase pathways in cancer. Toxicol Sci 120(1):14\u201332","journal-title":"Toxicol Sci"},{"issue":"5191","key":"9578_CR42","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.7992057","volume":"266","author":"A Minden","year":"1994","unstructured":"Minden A et al (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266(5191):1719\u20131723","journal-title":"Science"},{"issue":"3","key":"9578_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00246-010-9879-2","volume":"32","author":"AJ Muslin","year":"2011","unstructured":"Muslin AJ (2011) Akt2: a critical regulator of cardiomyocyte survival and metabolism. Pediatr Cardiol 32(3):317\u2013322","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"9578_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74(4):609\u2013619","journal-title":"Cell"},{"issue":"12","key":"9578_CR45","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1074\/mcp.M900285-MCP200","volume":"8","author":"C Pan","year":"2009","unstructured":"Pan C et al (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteom 8(12):2796\u20132808","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"9578_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cellsig.2007.07.010","volume":"20","author":"A Parcellier","year":"2008","unstructured":"Parcellier A et al (2008) PKB and the mitochondria: AKTing on apoptosis. Cell Signal 20(1):21\u201330","journal-title":"Cell Signal"},{"issue":"Suppl 2","key":"9578_CR47","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1053\/j.seminoncol.2014.01.002","volume":"41","author":"CM Walko","year":"2014","unstructured":"Walko CM, Grande C (2014) Management of common adverse events in patients treated with sorafenib: nurse and pharmacist perspective. Semin Oncol 41(Suppl 2):S17\u2013S28","journal-title":"Semin Oncol"},{"key":"9578_CR48","first-page":"9583268","volume":"2016","author":"P Xia","year":"2016","unstructured":"Xia P, Liu Y, Cheng Z (2016) Signaling pathways in cardiac myocyte apoptosis. Biomed Res Int 2016:9583268","journal-title":"Biomed Res Int"},{"issue":"3","key":"9578_CR49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1067\/mcp.2001.118244","volume":"70","author":"DE Mager","year":"2001","unstructured":"Mager DE, Jusko WJ (2001) Pharmacodynamic modeling of time-dependent transduction systems. Clin Pharmacol Ther 70(3):210\u2013216","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"9578_CR50","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1021\/js980171q","volume":"87","author":"A Sharma","year":"1998","unstructured":"Sharma A, Ebling WF, Jusko WJ (1998) Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci 87(12):1577\u20131584","journal-title":"J Pharm Sci"},{"issue":"3","key":"9578_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1124\/jpet.115.224766","volume":"354","author":"VL Chudasama","year":"2015","unstructured":"Chudasama VL et al (2015) Logic-based and cellular pharmacodynamic modeling of bortezomib responses in U266 human myeloma cells. J Pharmacol Exp Ther 354(3):448\u2013458","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9578_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE et al (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15(1):49\u201363","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9578_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E (2008) LC3 and Autophagy. Methods Mol Biol 445:77\u201388","journal-title":"Methods Mol Biol"},{"issue":"Pt 22","key":"9578_CR54","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1242\/jcs.115865","volume":"125","author":"AD Rubinstein","year":"2012","unstructured":"Rubinstein AD, Kimchi A (2012) Life in the balance\u2014a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci 125(Pt 22):5259\u20135268","journal-title":"J Cell Sci"},{"issue":"4","key":"9578_CR55","doi-asserted-by":"publisher","first-page":"E42","DOI":"10.1208\/ps040442","volume":"4","author":"ED Lobo","year":"2002","unstructured":"Lobo ED, Balthasar JP (2002) Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro. AAPS PharmSci 4(4):E42","journal-title":"AAPS PharmSci"},{"issue":"1","key":"9578_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cr.7290262","volume":"15","author":"J Liu","year":"2005","unstructured":"Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15(1):36\u201342","journal-title":"Cell Res"},{"issue":"3","key":"9578_CR57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/01.RES.88.3.305","volume":"88","author":"P Andreka","year":"2001","unstructured":"Andreka P et al (2001) Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 88(3):305\u2013312","journal-title":"Circ Res"},{"issue":"3","key":"9578_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0008-6363(03)00498-X","volume":"59","author":"A Gonz\u00e1lez","year":"2003","unstructured":"Gonz\u00e1lez A et al (2003) Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59(3):549\u2013562","journal-title":"Cardiovasc Res"},{"issue":"5","key":"9578_CR59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cardfail.2006.02.002","volume":"12","author":"S Kunapuli","year":"2006","unstructured":"Kunapuli S, Rosanio S, Schwarz ER (2006) \u201cHow do cardiomyocytes die?\u201d apoptosis and autophagic cell death in cardiac myocytes. J Card Fail 12(5):381\u2013391","journal-title":"J Card Fail"},{"issue":"4","key":"9578_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF01061691","volume":"21","author":"NL Dayneka","year":"1993","unstructured":"Dayneka NL, Garg V, Jusko WJ (1993) Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21(4):457\u2013478","journal-title":"J Pharmacokinet Biopharm"},{"issue":"21","key":"9578_CR61","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y et al (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19(21):5720\u20135728","journal-title":"EMBO J"},{"key":"9578_CR62","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong M et al (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2:e244","journal-title":"Cell Death Dis"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-018-9578-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-018-9578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-018-9578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T04:34:55Z","timestamp":1603859695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-018-9578-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9578"],"URL":"https:\/\/doi.org\/10.1007\/s10928-018-9578-9","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"13 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}